Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
J. Clin. Invest. Takuma Aikawa, et al. 118:89 doi:10.1172/JCI32412 [
Go to this article.]
Figure 6Effects of GPC1 levels on PCNA immunoreactivity in subcutaneous tumors. Morphometric analysis of PCNA immunoreactivity was performed as described in Methods, using 10 tumors from sham-transfected PANC-1 cells, 6 tumors from GAS6 cells, and 9 tumors from GAS7 cells. Data are means ± SEM. *
P < 0.01 compared with sham.
